To aid patient stratification, IHC-based scoring systems such as the Tumor Proportion Score (TPS) quantify PD-L1-positive tumor cells, with approximately 61% of gliomas exhibiting at least 1% positivity (75). The gene discussed is CD274; the disease is neoplasm.